Duke Neurology Research Round Up, August 2020
Members of the Duke Neurology Department contributed to 14 new peer-reviewed articles published this July, improving our understanding of neuroscience, charting a course for research in a post-COVI
Did Lou Gehrig experience a temporary ALS reversal in August 1938?
Nineteen thirty-eight was the last full season played by baseball slugger Lou Gehrig before amyotrophic lateral sclerosis (ALS) forced him to retire.
Resident Spotlight: Dylan Ryan, MD
When he first entered Duke University as an undergraduate, Dylan Ryan, MD, wanted to study chemistry, before a growing interest in the life sciences drew him first to study biology and then to
Staff Spotlight: Jessica Carlson
Jessica Carlson grew up with a “super mom” who was always present with affection, support, and a willingness to take her daughter to tennis meets every weekend in blazing summer heat.
Fellow Spotlight: Derek Neupert, MD
Derek Neupert, MD, was first drawn to neurology after he saw the lasting, devastating impact a stroke had on his grandmother.
Resident Spotlight: Charles "Hunter" Roark, DO
When Charles “Hunter” Roark, DO, came to Duke last year, he wasn’t expecting to have to adjust to an unexpected global pandemic in addition to his internal medicine residency.
Duke Neurology Research Round Up, July 2020
New research from the Duke Neurology Department advanced our understanding of neurological diseases and patient care at the basic science, translational, and clinical levels.
Duke Neurology congratulates the graduating residency class of 2020
The Duke Neurology residency class of 2020 held their graduation virtually this week, celebrating the completion of their four years of training and contributions to our Department amidst departmen
Staff Spotlight: Jillian Deignan
In addition to the development and administration of a potential therapy and following participants over time, every clinical trial also has a complex set of budgeting and financial concerns.
Gregory selected to 10x Genomics CTRN
The Molecular Genomics Core of Simon Gregory, PhD, was among the first 45 international members selected for participation in 10x Genomics Visium Clinical Translational Research Network (CTRN).